Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17471-43-1

Post Buying Request

17471-43-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17471-43-1 Usage

General Description

Hexahydro-2,5-methanopentalene-3a(1H)-methanol is a chemical compound with a unique structure that contains a cyclopentane ring fused to a cyclohexane ring, as well as a hydroxyl group. It is a colorless liquid at room temperature and is typically used as a solvent in various chemical processes. The compound is also used as a precursor in the synthesis of other organic compounds, and it has been investigated for its potential use in pharmaceutical applications. Hexahydro-2,5-methanopentalene-3a(1H)-methanol may have potential industrial and research uses due to its unique molecular structure and properties.

Check Digit Verification of cas no

The CAS Registry Mumber 17471-43-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,4,7 and 1 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 17471-43:
(7*1)+(6*7)+(5*4)+(4*7)+(3*1)+(2*4)+(1*3)=111
111 % 10 = 1
So 17471-43-1 is a valid CAS Registry Number.

17471-43-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Hexahydro-2,5-methanopentalene-3a(1H)-methanol

1.2 Other means of identification

Product number -
Other names 3-Noradamantyljodid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17471-43-1 SDS

17471-43-1Downstream Products

17471-43-1Relevant articles and documents

-

Adams,B.L.,Kovacic,P.

, p. 1310 - 1311 (1972)

-

Intramolecular C-H Amination Reaction Provides Direct Access to 1,2-Disubstituted Diamondoids

Hrdina, Radim,Metz, Fabian M.,Larrosa, Marta,Berndt, Jan-Philipp,Zhygadlo, Yevgeniya Y.,Becker, Sabine,Becker, Jonathan

, p. 6231 - 6236 (2015)

We present a new approach to disubstituted diamondoids from corresponding carboxylic acids. A dirhodium-acetate-catalyzed (1 mol-%) nitrene insertion reaction of sulfamides was, for the first time, applied to intramolecular C-H functionalization reactions of rigid tricyclic frameworks. This straightforward approach enables the effective and regioselective synthesis of a variety of diamondoid-based cyclic sulfamidates, which are synthetically valuable building blocks. Reductive deprotection of the sulfamidate moiety leads to corresponding 1,3-amino alcohol derivatives. Oxidation of the sulfamidate moiety by KMnO4 provides access to 1,3-keto alcohols or imines. Finally, we report the synthesis of Vildagliptin analogues as new antidiabetic drug candidates (DPP-4 inhibitors). Intramolecular dirhodium-acetate-catalyzed (1 mol-%) nitrene insertion reactions provide direct access to 1,2-disubstituted diamondoids. This approach was applied to the synthesis of Vildagliptin (DPP-4 inhibitor) analogues.

-Rearrangement of iminium salts provides access to heterocycles with adamantane scaffold

Becker, Jonathan,Duman, Ediz,Hausmann, Heike,Hrdina, Radim,Zonker, Benjamin

, p. 4941 - 4945 (2020)

We describe a Br?nsted acid-catalysed cascade reaction consisting of a Wagner-Meerwein rearrangement and a subsequent intra- or intermolecular Friedel-Crafts reaction leading to adamantane-based heterocycles. In contrast to the reported W.-M. rearrangements, in this case an iminium moiety serves as the acceptor of a migrating nucleophilic alkyl group in a [1,2]-alkyl shift. This journal is

Discovery of adamantane based highly potent HDAC inhibitors

Gopalan, Balasubramanian,Ponpandian, Thanasekaran,Kachhadia, Virendra,Bharathimohan, Kuppusamy,Vignesh, Radhakrishnan,Sivasudar, Velaiah,Narayanan, Shridhar,Mandar, Bhonde,Praveen, Rajendran,Saranya, Nithyanandan,Rajagopal, Sriram,Rajagopal, Sridharan

, p. 2532 - 2537 (2013/06/27)

Herein, we report the development of highly potent HDAC inhibitors for the treatment of cancer. A series of adamantane and nor-adamantane based HDAC inhibitors were designed, synthesized and screened for the inhibitory activity of HDAC. A number of compounds exhibited GI50 of 10-100 nM in human HCT116, NCI-H460 and U251 cancer cells, in vitro. Compound 32 displays efficacy in human tumour animal xenograft model.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17471-43-1